Discontinued — last reported Q2 '21

Other

Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost

Edwards Lifesciences Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost decreased by 16.5% to $39.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 26.2%, from $53.00M to $39.10M.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ1 2016
Last reportedQ2 2021
Metric ID: other_heldtomaturity_securities_debt_maturities_next_rol_542346

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$35.00M$83.00M$160.00M$62.50M$118.50M$23.50M$26.30M$28.00M$56.00M$53.40M$50.50M$53.00M$44.70M$46.80M$39.10M
QoQ Change—+137.1%+92.8%-60.9%+89.6%-80.2%+11.9%+6.5%+100.0%-4.6%-5.4%+5.0%-15.7%+4.7%-16.5%
YoY Change———+78.6%+42.8%-85.3%-57.9%-76.4%+138.3%+103.0%+80.4%-5.4%-16.3%-7.3%-26.2%
Range$23.50M – $160.00M
CAGR+3.2%
Avg YoY Growth+14.0%
Median YoY Growth-6.3%

Frequently Asked Questions

What is Edwards Lifesciences's debt securities, held-to-maturity, maturity, allocated and single maturity date, rolling within one year, amortized cost?
Edwards Lifesciences (EW) reported debt securities, held-to-maturity, maturity, allocated and single maturity date, rolling within one year, amortized cost of $39.10M in Q1 2026.
How has Edwards Lifesciences's debt securities, held-to-maturity, maturity, allocated and single maturity date, rolling within one year, amortized cost changed year-over-year?
Edwards Lifesciences's debt securities, held-to-maturity, maturity, allocated and single maturity date, rolling within one year, amortized cost decreased by 26.2% year-over-year, from $53.00M to $39.10M.